* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Anxiety. Drug treatments
Antipsychotic wikipedia , lookup
Mental disorder wikipedia , lookup
Narcissistic personality disorder wikipedia , lookup
Selective mutism wikipedia , lookup
Rumination syndrome wikipedia , lookup
Substance dependence wikipedia , lookup
Classification of mental disorders wikipedia , lookup
Diagnostic and Statistical Manual of Mental Disorders wikipedia , lookup
Alcohol withdrawal syndrome wikipedia , lookup
History of psychiatric institutions wikipedia , lookup
Spectrum disorder wikipedia , lookup
Asperger syndrome wikipedia , lookup
Moral treatment wikipedia , lookup
History of psychiatry wikipedia , lookup
Mental status examination wikipedia , lookup
Conversion disorder wikipedia , lookup
Controversy surrounding psychiatry wikipedia , lookup
Glossary of psychiatry wikipedia , lookup
Child psychopathology wikipedia , lookup
Dissociative identity disorder wikipedia , lookup
Emergency psychiatry wikipedia , lookup
Panic disorder wikipedia , lookup
History of mental disorders wikipedia , lookup
Abnormal psychology wikipedia , lookup
Anxiety disorder wikipedia , lookup
Claustrophobia wikipedia , lookup
Pharmaceutical guidelines of patients with pathology of CNS organs. Symptomatic treatment of ASTHENIA AND ANXIETY Asthenia • Asthenia: Weakness. Lack of energy and strength. Loss of strength. The word asthenia is not much used in medicine today, although it is a prominent part of myasthenia, a loss of muscle strength, as in myasthenia gravis. Asthenia • It is a frequent cause of consult, almost 30% in ambulatory settings. The chronic fatigue represents up to 10% of these cases, and the 0.20.7% belongs to the chronic fatigue syndrome. • It is very important to differentiate asthenia from weakness, dizziness or dyspnoea, since patients may confuse them. The factor time in asthenia is very useful for its characterization, it was defined to the prolonged fatigue when it lasts for more than a month and chronic when the duration is greater than 6 months. • The depression is the commonest fatigue cause, representing approximately half of the cases. Asthenia • General asthenia occurs in many chronic wasting diseases anemia and cancer, is probably most marked in diseases of the adrenal gland. Asthenia may be limited to certain organs or systems of organs, as in asthenopia, characterized by ready fatiguability. Asthenia is also a side effect of Ritonavir (Protease Inhibitor used in HIV treatment) and fentanyl patches (an opioid used to treat pain). The condition is also commonly seen in patients suffering from chronic fatigue syndrome, sleep disorders or chronic disorders of the heart, lungs or kidneys. Differentiating between psychogenic asthenia and true asthenia with muscular weakness is often difficult, and in time apparent psychogenic asthenia accompanying many chronic disorders is seen to progress into a primary weakness. Chronic fatigue syndrome (CFS) ‘functional’ syndrome • uncertain classification as neurasthenia in the psychiatric classification and myalgic encephalomyelitis (ME) under neurological diseases. • It occurs most commonly in women between the ages of 20 and 50 years. • The cardinal symptom is chronic fatigue made worse by minimal exertion. The fatigue is usually both physical and mental, associated most commonly with poor concentration, impaired registration of memory, alteration in sleep pattern (either insomnia or hypersomnia), and muscular pain. • • Mood disorders are present in a large minority of patients, and can cause problems in diagnosis because of the large overlap in symptoms.These mood disorders may be secondary, independent (co-morbid), or primary (with a misdiagnosis of CFS). • The most effective treatment of the asthenia is to solve the underlying cause, although up to 20% of the patients remain without diagnosis. The diagnosis of the chronic fatigue syndrome is of exclusion and the criteria of the international consensus of year 1994 are due to use. The high frequency of the symptom entails an enormous social and economic cost and it is for that reason so important for physicians to have a correct manage of this symptom. Treatment of asthenic syndrome • includes a variety of approaches: psychotherapy, lifestyle changes, the ordering of work and leisure modes of wakefulness and sleep, regular meals, eliminating the causes of emotional stress, physical therapy, spa treatment. • In some cases, such events can bring tangible benefits and rights to withdraw from the state of fatigue. However, for obvious reasons, these recommendations are not always feasible. On the other hand, in some cases, these measures are insufficient, and the doctor had to resort to medication. Asthenic syndromes treatment • Asthenic syndromes with symptoms of a "simple" fatigue (feeling tired, increased sensitivity to external stimuli and pathological bodily sensations) are preferred tranquilizers narrow spectrum of action - oxazepam, medazepam, tofizapam, trioxazine in combination with stimulants and nootropics Nootropic drugs with stimulant properties: • deanol aceglumat, • salbutiamin • Ladasten (adamantylbromphenilamin) Anxiety • Anxiety is a feeling of constant, inappropriate or excessive worry, fear, apprehension, tension or inner restlessness, seen in anxiety and depressive disorders as well as drug withdrawal. ANXIETY DISORDERS • are classified according to whether the anxiety is persistent (general anxiety) or episodic, with the episodic conditions classified according to whether the episodes are regularly triggered by a cue (phobia) or not (panic disorder). General anxiety disorder • This occurs in 4–6% of the population and is more common in women. Symptoms are persistent and often chronic. • General anxiety disorder (GAD) and its related panic disorder are differential diagnoses for functional somatic syndromes, owing to the many physical symptoms that are caused by these conditions. Anxiety disorder caused by physical diseases • • • • • Thyrotoxicosis Hypoglycaemia (transient) Phaeochromocytoma Complex partial seizures (transient) Alcohol withdrawal Physical and psychological symptoms of anxiety Physical symptoms • • • • • • • • • • • • • • • Gastrointestinal Dry mouth Difficulty in swallowing Epigastric discomfort Aerophagy (swallowing air) ‘Diarrhoea’ (usually frequency) Respiratory Feeling of chest constriction Difficulty in inhaling Overbreathing Choking Cardiovascular Palpitations Awareness of missed beats Chest pain Physical and psychological symptoms of anxiety Physical symptoms • • • • • • • • • • • • Genitourinary Increased frequency Failure of erection Lack of libido Nervous system Fatigue Blurred vision Dizziness Sensitivity to noise and/or light Headache Sleep disturbance Trembling Physical and psychological symptoms of anxiety • • • • • • • Psychological symptoms Apprehension and fear Irritability Difficulty in concentrating Distractibility Restlessness Depersonalization Derealization Panic disorder • Panic disorder is diagnosed when the patient has repeated sudden attacks of overwhelming anxiety, accompanied by severe physical symptoms, usually related to both hyperventilation and sympathetic nervous system activity (palpitations, tremor, restlessness and sweating). • The lifetime prevalence is 5%. Patients with panic disorder often have catastrophic illness beliefs during the panic attack, such as convictions that they are about to die from a stroke or heart attack. • The fear of a stroke is related to dizziness and headache. • Fear of a heart attack accompanies chest pain (atypical chest pain). • The occasional patient with long-standing attacks may deny feeling anxious and simply report the physical symptoms. Aetiology • General anxiety and panic disorders occur four or more times as commonly in first-degree relatives of affected patients, suggesting a genetic influence. • Sympathetic nervous system overactivity, increased muscle tension and hyperventilation are the common pathophysiological mechanisms. Anxiety is the emotional response to the threat of a loss, whereas depression is the response to the loss itself. Phobic (anxiety) disorders • Phobias are common conditions in which intense fear is triggered by a stimulus, or group of stimuli, that are predictable and normally cause no particular concern to others (e.g. agoraphobia, claustrophobia, social phobia). • This leads to avoidance of the stimulus. The patient knows that the fear is irrational, but cannot control it. The prevalence of all phobias is 8%, with many patients having more than one. • Many phobias of ‘medical’ stimuli exist (e.g. of doctors, dentists, hospitals, vomit, blood and injections) which affect the patient’s ability to receive adequate healthcare. Phobic (anxiety) disorders (cont’d) • Women have twice the prevalence of most phobias than men. • Agoraphobia - common phobia (4% prevalence) presents as a fear of being away from home, with avoidance of travelling, walking down a road and supermarkets being common cues. This can be a very disabling condition, since the patient can be too unwell to ever leave home, particularly by themselves. It is often associated with claustrophobia, a fear of enclosed spaces. Phobic (anxiety) disorders (cont’d) • Social phobia - the fear and avoidance of social situations: crowds, strangers, parties and meetings. Public speaking would be the sufferer’s worst nightmare. It is suffered by 2% of the population. • Simple phobias - The commonest is the phobia of spiders (arachnophobia), particularly in women. The prevalence of simple phobias is 7% in the general population. • Other common phobias include insects, moths, bats, dogs, snakes, heights, thunderstorms and the dark. • Children are particularly phobic about the dark, ghosts and burglars, but the large majority grow out of these fears. Treatment of anxiety disorders • Psychological treatments ■ Relaxation techniques can be effective in mild/moderate anxiety. Relaxation can be achieved in many ways, including complementary techniques such as meditation and yoga. Conventional relaxation training involves slowing down the rate of breathing, muscle relaxation and mental imagery. ■ Anxiety management training involves two stages. In the first stage, verbal cues and mental imagery are used to arouse anxiety to demonstrate the link with symptoms. In the second stage, the patient is trained to reduce this anxiety by relaxation, distraction and reassuring self-statements. Treatment of anxiety disorders(cont’d) • Behaviour therapies are treatments that are intended to change behaviour and thus symptoms. The most common and successful behaviour therapy (with 80% success in some phobias) is graded exposure, otherwise known as systematic desensitization. First, the patient rates the phobia into a hierarchy or ‘ladder’ of worsening fears (e.g. in agoraphobia: walking to the front door with a coat on; walking out into the garden; walking to the end of the road). Second, the patient practises exposure to the least fearful stimulus until no fear is felt. The patient then moves ‘up the ladder’ of fears until they are cured. Treatment of anxiety disorders(cont’d) ■ Cognitive behaviour therapy (CBT) is the treatment of choice for panic disorder and general anxiety disorder because the therapist and patient need to identify the mental cues (thoughts and memories) that may subtly provoke exacerbations of anxiety or panic attacks. Drug treatments • Initial ‘drug’ treatment should involve advice to gradually cease taking anxiogenic recreational drugs such as caffeine and alcohol (which can cause a rebound anxiety and withdrawal). • Prescribed drugs used in the treatment of anxiety can be divided into two groups: - those that act primarily on the central nervous system, - those that block peripheral autonomic receptors. Benzodiazepines • • • • are centrally acting anxiolytic drugs They bind to specific receptors that stimulate release of the inhibitory transmitter γ-aminobutyric acid (GABA) Diazepam (5 mg twice daily, up to 10 mg three times daily in severe cases), alprazolam (250–500 μg three times daily) and chlordiazepoxide have relatively long half-lives (20–40 hours) and are used as anti-anxiety drugs in the short term. Side-effects include sedation and memory problems, and patients should be advised not to drive while on treatment. They can cause dependence and tolerance within 4–6 weeks, particularly in dependent personalities. The withdrawal syndrome can occur after just 3 weeks of continuous use and is particularly severe when high doses have been given for a longer time. Withdrawal syndrome with benzodiazepines • • • • • • • • Insomnia Anxiety Tremulousness Muscle twitchings Perceptual distortions Hallucinations (which may be visual) Hypersensitivities (light, sound, touch) Convulsions Benzodiazepines • If a benzodiazepine drug is prescribed for anxiety, it should be given in as low a dose as possible, preferably on an ‘as necessary’ basis, and for not more than 2–4 weeks. A withdrawal programme from chronic use includes changing the drug to the longacting diazepam, followed by a very gradual reduction in dosage. Anxiety. Drug treatments SELECTIVE SEROTONIN REUPTAKE INHIBITORS • Most SSRIs (e.g. fluoxetine, paroxetine, sertraline, escitalopram, citalopram) are useful symptomatic treatments for general anxiety and panic disorders, as well as some phobias (social phobia). Imipramine and clomipramine are alternative symptomatic treatments for panic disorder and GAD. Treatment response is often delayed several weeks; a trial of treatment should last 3 months. Anxiety. Drug treatments TRICYCLIC/POLYCYCLIC ANTIDEPRESSANTS (block norepinephrine, and serotonin uptake into the neuron) • Imipramine and clomipramine are alternative symptomatic treatments for panic disorder and GAD. Treatment response is often delayed several weeks; a trial of treatment should last 3 months. Anxiety. Drug treatments • Many of the symptoms of anxiety are due to an increased or sustained release of epinephrine (adrenaline) and norepinephrine (noradrenaline) from the adrenal medulla and sympathetic nerves. Thus, betablockers such as propranolol (20–40 mg two or three times daily) are effective in reducing peripheral symptoms such as palpitations, tremor and tachycardia, but do not help central symptoms such as anxiety.